Skip to content

Opening book details…

Can I read Removal of Noninfected Arteriovenous Fistulae after Kidney Transplantation is a Safe and Beneficial Management Strategy for Unused Dialysis Access on EtoBox?

Removal of Noninfected Arteriovenous Fistulae after Kidney Transplantation is a Safe and Beneficial Management Strategy for Unused Dialysis Access by Charles D. Fraser; Joshua C. Grimm; Rui Han Liu; Russell N. Wesson; Faris Azar; Robert J. Beaulieu; Thomas Reifsnyder is a Medicine article available to read on EtoBox.

What is Removal of Noninfected Arteriovenous Fistulae after Kidney Transplantation is a Safe and Beneficial Management Strategy for Unused Dialysis Access about?

## Background: Renal transplant recipients often maintain their hemodialysis access in the event of future allograft failure. patients may develop complications related to the unused dialysis access, and it also limits vein availability for phlebotomy. accordingly, a change in the current paradigm may be warranted. this study evaluates the indications for, and safety of, arteriovenous fistula (avf) removal in patients after successful renal transplantation. ## Methods: All patients who underwent avf excision at a single institution from 2006 to 2016 were retrospectively reviewed. within that cohort, those undergoing removal after renal transplantation were included for analysis. baseline patient characteristics, including renal function at the time of removal, reason for excision, and age of the avf, were examined. the primary outcome was the need for dialysis after avf removal. ## Results: A total of 114 patients, of which 36 (31.6%) were recipients of renal transplants, underwent fistula removal during the study period. within the transplant cohort, the median fistula age at the time of excision was 1,903 days (interquartile range: 556-3,394 days). the most common indications for

Who reads Removal of Noninfected Arteriovenous Fistulae after Kidney Transplantation is a Safe and Beneficial Management Strategy for Unused Dialysis Access?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Charles D. Fraser; Joshua C. Grimm; Rui Han Liu; Russell N. Wesson; Faris Azar; Robert J. Beaulieu; Thomas Reifsnyder
Publisher
Springer; Elsevier ; Elsevier Inc.; Elsevier BV; Springer Science and Business Media LLC (ISSN 0890-5096)
Published
2018
Language
EN
Field
Medicine (Health Sciences)

More by Charles D. Fraser; Joshua C. Grimm; Rui Han Liu; Russell N. Wesson; Faris Azar; Robert J. Beaulieu; Thomas Reifsnyder

Browse all works by Charles D. Fraser; Joshua C. Grimm; Rui Han Liu; Russell N. Wesson; Faris Azar; Robert J. Beaulieu; Thomas Reifsnyder